Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.495 USD | +3.46% | -17.79% | -46.03% |
Mar. 18 | Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
Mar. 15 | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 40.7M | Sales 2025 * | 49.94M | Capitalization | 7.61M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -3M | EV / Sales 2024 * | 0.19 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.15 x |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-2.74
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.65% |
Latest transcript on Biofrontera Inc.
1 day | +3.46% | ||
1 week | -17.79% | ||
Current month | -2.92% | ||
1 month | +24.58% | ||
3 months | -9.94% | ||
6 months | -61.17% | ||
Current year | -46.03% |
Managers | Title | Age | Since |
---|---|---|---|
Hermann Lübbert
CEO | Chief Executive Officer | 68 | 15-02-28 |
Fred Leffler
DFI | Director of Finance/CFO | 41 | 22-10-23 |
Erica Gates
DFI | Director of Finance/CFO | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Borer
BRD | Director/Board Member | 67 | 21-11-01 |
Hermann Lübbert
CEO | Chief Executive Officer | 68 | 15-02-28 |
Kevin D. Weber
BRD | Director/Board Member | 66 | 22-03-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.495 | +3.46% | 54,109 |
24-04-22 | 1.445 | -14.50% | 93,931 |
24-04-19 | 1.69 | +1.20% | 66,235 |
24-04-18 | 1.67 | -2.34% | 40,755 |
24-04-17 | 1.71 | -5.97% | 77,437 |
Delayed Quote Nasdaq, April 23, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.03% | 7.61M | |
+27.92% | 672B | |
+27.68% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+6.30% | 217B | |
+4.80% | 199B | |
-6.05% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- BFRI Stock